Loading patent…
AssigneeAmgen Inc.
InventorsBrian K. Albrecht, David Bauer, Christiane M. Bode, Shon Booker, Alessandro Boezio, Deborah Choquette, Derin D'Amico, Jean-Christophe Harmange, Satoko Hirai, Richard T. Lewis, Longbin Liu, Julia Lohman, Mark H. Norman, Michele Potashman, Aaron C. Siegmund, Stephanie K. Springer, Markian Stec, Ning Xi, Kevin Yang
Estimating the term…
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
A compound selected from
A compound or a pharmaceutically acceptable salt thereof, selected from
A compound or a pharmaceutically acceptable salt thereof, selected from
A compound or a pharmaceutically acceptable salt thereof, selected from
A compound or a pharmaceutically acceptable salt thereof, selected from
A method of treating gastric cancer or glioblastoma in a subject, said method comprising administering an effective amount of a compound as in any of the preceding claims.
Dependencies are inferred from the claim text.